pravastatin has been researched along with Hyperhomocysteinemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aukrust, P; Holven, KB; Nenseter, MS; Ose, L | 1 |
| Schück, O; Stollová, M; Teplan, V; Vítko, S | 1 |
| Constans, J | 1 |
3 other study(ies) available for pravastatin and Hyperhomocysteinemia
| Article | Year |
|---|---|
Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Case-Control Studies; Cells, Cultured; Chemokines; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Inflammation Mediators; Leukocytes, Mononuclear; Male; Middle Aged; Pravastatin; Pyrroles; Simvastatin; Young Adult | 2014 |
Obesity and hyperhomocysteinaemia after kidney transplantation.
Topics: Adult; Aged; Cohort Studies; Combined Modality Therapy; Diet Therapy; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperhomocysteinemia; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Obesity; Postoperative Complications; Pravastatin; Probability; Prospective Studies; Risk Assessment; Treatment Outcome; Vitamin B 6 | 2003 |
[Atherosclerosis. Congress of the European Atherosclerosis Society (EAS), Athens (Greece), 26-29 May 1999].
Topics: Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Ascorbic Acid; Cholesterol, LDL; Diet; Europe; Folic Acid; Greece; Humans; Hyperhomocysteinemia; Lipoproteins; Pravastatin; Pyridoxine; Risk Factors; Societies, Medical; Triglycerides | 1999 |